Findi Raises $9M, Cancels Nova Deal, Boosts Stake in TSI
Findi Limited has secured $9 million in the first tranche of its $25 million placement, enabling debt reduction and strategic shifts including the cancellation of the Nova transaction and increased ownership in Transaction Solutions International.
- Completed settlement of Tranche 1 raising $9 million
- Refinanced and optimised TSI balance sheet
- Cancelled previously announced Nova transaction
- Increased ownership stake in TSI
- Restarted rollout programs with major Indian banks
Capital Injection and Strategic Shift
Findi Limited (ASX:FND) has successfully completed the first tranche of its $25 million institutional placement, raising $9 million. This capital injection is a pivotal step in refinancing and optimising the balance sheet of its subsidiary, Transaction Solutions International (TSI). The move is expected to unlock cash flow, materially reduce gross debt, and lower interest costs, strengthening Findi’s financial position.
Cancellation of Nova Transaction and Ownership Boost
Significantly, Findi has decided to cancel the previously announced Nova transaction. This cancellation means the company will retain a substantially higher ownership stake in TSI, which could translate into greater control and a larger share of future profits. The decision marks a strategic pivot, suggesting confidence in TSI’s standalone potential and a desire to capitalise on its growth opportunities directly.
Accelerated Growth in Indian Market
With the balance sheet optimised and ownership consolidated, Findi is well positioned to restart deployment of key rollout programs with the State Bank of India and Central Bank of India. These initiatives are critical for expanding TSI’s footprint in the Indian digital payments market. Additionally, enhanced platform liquidity is expected to accelerate growth in BankIT and White Label transactions, further boosting TSI’s market share in one of the world’s fastest-growing financial services sectors.
Next Steps and Market Implications
The shares issued under Tranche 1 will begin trading on the ASX on 20 March 2026. Meanwhile, the second tranche of the placement, which will raise the remaining $16 million, awaits shareholder approval at a general meeting scheduled for 20 April 2026. The outcome of this vote will be closely watched as it will determine the full extent of Findi’s capital raising and its capacity to execute its strategic plans.
Overall, this tranche settlement marks a significant milestone for Findi, signalling a more streamlined capital structure and a renewed focus on growth in the Indian market. Investors will be keen to see how the company leverages its increased stake in TSI and the progress of its bank rollout programs in the coming months.
Bottom Line?
Findi’s capital raise and strategic realignment set the stage for accelerated growth, but shareholder approval for the next tranche remains a key hurdle.
Questions in the middle?
- Will shareholders approve the second tranche of the placement in April?
- How will the cancellation of the Nova transaction impact Findi’s long-term growth trajectory?
- What progress can be expected from the State Bank of India and Central Bank of India rollout programs?
